SiRNA Inventions At The EPO (Video)

J A Kemp is a leading firm of European Patent and Trade Mark Attorneys. We combine independent thinking with collective excellence in all that we do. The technical and legal knowledge that we apply to the protection of our clients’ patents is outstanding in its breadth and depth. With around 100 science and technology graduates in the firm, including 50 PhDs, no area of science or technology is outside our scope. Our Patent Attorneys have collective in-depth expertise in patent law and procedure in every country of the world. The team of professionals who advise our clients on trade mark and design matters have backgrounds in major international law firms and hold qualifications as Chartered UK Trade Mark Attorneys, Solicitors and European Trade Mark Professional Representatives. Dedicated to this specialist area of intellectual property protection, the team has the expertise and resources to protect trade marks and designs in any market worldwide.

Explore Firm Details

Therapies based on small interfering RNAs (siRNAs) have recently hit the headlines with one drug effecting significant clinical improvements in patients suffering from motor neuron disease.

United Kingdom

Therapies based on small interfering RNAs (siRNAs) have recently hit the headlines with one drug effecting significant clinical improvements in patients suffering from motor neuron disease. Other therapies are also being developed and there can be no doubt regarding the potential for these new siRNA drugs. In this webinar we will explore how the European Patent Office (EPO) views inventions in this field and discuss obstacles innovators are likely to face when protecting their inventions.

Topics covered will include:

Patent landscape
Challenges
How shall we claim it, and when?
Where is practice going next?
Is practice diverging in EP and US?

self

Contributor

Explore Firm Details

See More Popular Content From